NEW YORK (GenomeWeb) – As part of an effort to build a Small Cell Lung Cancer (SCLC) Consortium, National Cancer Institute announced that it intends to fund research that will support the development of new molecular diagnostics and screening approaches for populations at high risk of developing the disease.

The agency said that approved projects may receive up to $450,000 in annual direct costs for up to five years, with the total number of awards depending on National Institutes of Health appropriations.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.